-
Je něco špatně v tomto záznamu ?
Freeze-drying as suitable method to achieve ready-to-use yeast biosensors for androgenic and estrogenic compounds
S. Jarque, M. Bittner, K. Hilscherová,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- alfa receptor estrogenů genetika MeSH
- androgenní receptory genetika MeSH
- androgeny farmakologie MeSH
- antagonisté estrogenového receptoru MeSH
- biosenzitivní techniky metody MeSH
- biotest metody MeSH
- endokrinní disruptory farmakologie MeSH
- estrogeny farmakologie MeSH
- kryoprotektivní látky farmakologie MeSH
- lyofilizace metody MeSH
- mikrobiální viabilita účinky léků MeSH
- monitorování životního prostředí metody MeSH
- reprodukovatelnost výsledků MeSH
- Saccharomyces cerevisiae účinky léků genetika MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Recombinant yeast assays (RYAs) have been proved to be a suitable tool for the fast screening of compounds with endocrine disrupting activities. However, ready-to-use versions more accessible to less equipped laboratories and field studies are scarce and far from optimal throughputs. Here, we have applied freeze-drying technology to optimize RYA for the fast assessment of environmental compounds with estrogenic and androgenic potencies. The effects of different cryoprotectants, initial optical density and long-term storage were evaluated. The study included detailed characterization of sensitivity, robustness and reproducibility of the new ready-to-use versions, as well as comparison with the standard assays. Freeze-dried RYAs showed similar dose-responses curves to their homolog standard assays, with Lowest Observed Effect Concentration (LOEC) and Median effective Concentration (EC50) of 1 nM and 7.5 nM for testosterone, and 0.05 nM and 0.5 nM for 17β-estradiol, respectively. Freeze-dried cells stored at 4 °C retained maximum sensitivity up to 2 months, while cells stored at -18 °C showed no decrease in sensitivity throughout the study (10 months). This ready-to-use RYA is easily accessible and may be potentially used for on-site applications.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17000580
- 003
- CZ-PrNML
- 005
- 20170117095222.0
- 007
- ta
- 008
- 170103s2016 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.chemosphere.2016.01.038 $2 doi
- 024 7_
- $a 10.1016/j.chemosphere.2016.01.038 $2 doi
- 035 __
- $a (PubMed)26807940
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Jarque, Sergio $u Masaryk University, Faculty of Science, RECETOX, Kamenice 5/753, Brno CZ62500, Czech Republic.
- 245 10
- $a Freeze-drying as suitable method to achieve ready-to-use yeast biosensors for androgenic and estrogenic compounds / $c S. Jarque, M. Bittner, K. Hilscherová,
- 520 9_
- $a Recombinant yeast assays (RYAs) have been proved to be a suitable tool for the fast screening of compounds with endocrine disrupting activities. However, ready-to-use versions more accessible to less equipped laboratories and field studies are scarce and far from optimal throughputs. Here, we have applied freeze-drying technology to optimize RYA for the fast assessment of environmental compounds with estrogenic and androgenic potencies. The effects of different cryoprotectants, initial optical density and long-term storage were evaluated. The study included detailed characterization of sensitivity, robustness and reproducibility of the new ready-to-use versions, as well as comparison with the standard assays. Freeze-dried RYAs showed similar dose-responses curves to their homolog standard assays, with Lowest Observed Effect Concentration (LOEC) and Median effective Concentration (EC50) of 1 nM and 7.5 nM for testosterone, and 0.05 nM and 0.5 nM for 17β-estradiol, respectively. Freeze-dried cells stored at 4 °C retained maximum sensitivity up to 2 months, while cells stored at -18 °C showed no decrease in sensitivity throughout the study (10 months). This ready-to-use RYA is easily accessible and may be potentially used for on-site applications.
- 650 _2
- $a androgeny $x farmakologie $7 D000728
- 650 _2
- $a biotest $x metody $7 D001681
- 650 _2
- $a biosenzitivní techniky $x metody $7 D015374
- 650 _2
- $a kryoprotektivní látky $x farmakologie $7 D003451
- 650 _2
- $a endokrinní disruptory $x farmakologie $7 D052244
- 650 _2
- $a monitorování životního prostředí $x metody $7 D004784
- 650 _2
- $a antagonisté estrogenového receptoru $7 D065171
- 650 _2
- $a alfa receptor estrogenů $x genetika $7 D047628
- 650 _2
- $a estrogeny $x farmakologie $7 D004967
- 650 _2
- $a lyofilizace $x metody $7 D005612
- 650 _2
- $a mikrobiální viabilita $x účinky léků $7 D050296
- 650 _2
- $a androgenní receptory $x genetika $7 D011944
- 650 _2
- $a reprodukovatelnost výsledků $7 D015203
- 650 _2
- $a Saccharomyces cerevisiae $x účinky léků $x genetika $7 D012441
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bittner, Michal $u Masaryk University, Faculty of Science, RECETOX, Kamenice 5/753, Brno CZ62500, Czech Republic.
- 700 1_
- $a Hilscherová, Klára $u Masaryk University, Faculty of Science, RECETOX, Kamenice 5/753, Brno CZ62500, Czech Republic. Electronic address: hilscherova@recetox.muni.cz.
- 773 0_
- $w MED00002124 $t Chemosphere $x 1879-1298 $g Roč. 148, č. - (2016), s. 204-10
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26807940 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170103 $b ABA008
- 991 __
- $a 20170117095328 $b ABA008
- 999 __
- $a ok $b bmc $g 1179720 $s 961147
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 148 $c - $d 204-10 $e 20160122 $i 1879-1298 $m Chemosphere $n Chemosphere $x MED00002124
- LZP __
- $a Pubmed-20170103